Pancreatic β-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation

Biochemical Journal

Volumn 377, Issue 3, 2004, Pages 709-716

  Jaikaran, Emma T A S ^a,b,c   Nilsson, Melanie R ^a,c,d   Clark, Anne ^a,b  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d MCDANIEL COLLEGE   (United States)

Author keywords

Amyloid fibril; Diabetes; Insulin; Islet amyloid polypeptide; Type 2 diabetes; sheet

Indexed keywords

CELLS; IMMUNOLOGY; INSULIN; POLYPEPTIDES; SURFACE PLASMON RESONANCE; TRANSMISSION ELECTRON MICROSCOPY;

HETEROMOLECULAR COMPLEXES; MOLECULAR INTERACTIONS;

BIOCHEMISTRY;

AMYLIN; INSULIN; PROINSULIN;

ANIMAL CELL; ARTICLE; BETA CHAIN; BETA SHEET; CIRCULAR DICHROISM; COMPLEX FORMATION; CONTROLLED STUDY; DIMERIZATION; FIBER; GRANULE CELL; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; SURFACE PLASMON RESONANCE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALIA; MUS MUSCULUS;

EID: 1242292280     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/bj20030852     Document Type: Article

References (34)

1. Westermark, P., Wernstedt, C., Wilander, E., Hayden, D. W., O'Brien, T. D, and Johnson, K. H. (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc. Natl. Acad. Sci. U.S.A. 84, 3881-3885
2. Clark, A., Cooper, G. J., Lewis, C. E., Morris, J. F., Willis, A. C., Reid, K. B. and Turner, R. C. (1987) Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet II, 231-234
3. Betsholtz, C., Svensson, V, Rorsman, F., Engstrom, U., Westermark, G. T., Wilander, E., Johnson, K. and Westermark, P. (1989) Islet amyloid polypeptide (IAPP): cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus. Exp. Cell Res. 183, 484-493
4. Butler, P. C., Chou, J., Carter, W. B., Wang, Y. N., Bu, B. H., Chang, D., Chang, J. K. and Rizza, R. A. (1990) Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39, 752-756
5. Sanke, T., Hanabusa, T., Nakano, Y., Oki, C., Okai, K., Nishimura, S., Kondo, M. and Nanjo, K. (1991) Plasma islet amyloid polypeptide (amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34, 129-132
6. Badman, M. K., Shennan, K. I., Jermany, J. L., Docherty, K. and Clark, A. (1996) Processing of pro-islet amyloid polypeptide (proIAPP) by the prohormone convertase PC2. FEBS Lett. 378, 227-231
7. Bailyes, E. M., Bennett, D. L. and Hutton, J, C. (1991) Proprotein-processing endopeptidases of the insulin secretory granule. Enzyme 45, 301-313
8. Hutton, J. C. (1984) Secretory granules. Experientia 40, 1091-1098
9. Nishi, M., Sanke, T., Nagamatsu, S., Bell, G, I. and Steiner, D. F. (1990) Islet amyloid polypeptide. J. Biol. Chem. 265, 4173-4176
10. Castillo, M. J., Scheen, A. J. and Lefebvre, P. J. (1995) Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology. Diabetes Metab. 21, 3-25
11. Westermark, P., Li, Z. C., Westermark, G. T., Leckstrom, A. and Steiner, D. F. (1996) Effects of β-cell granule components on human islet amyloid polypeptide fibril formation. FEBS Lett. 379, 203-206
12. Kahn, S. E., Andrikopoulos, S. and Verchere, C. B. (1999) Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes 48, 241-253
13. Verchere, C. B., D'Alessio, D. A., Palmiter, R. D., Weir, G. C., Bonner Weir, S., Baskin, D. G. and Kahn, S. E. (1996) Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic β-cell expression of human islet amyloid polypeptide. Proc. Natl. Acad. Sci. U.S.A. 93, 3492-3496
14. Couce, M., Kane, L. A., O'Brien, T. D., Charlesworth, J., Soeller, W., McNeish, J., Kreutter, D., Roche, P. and Butler, P. C. (1996) Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and β-cell dysfunction. Diabetes 45, 1094-1101
15. Tsuzuki, K., Fukatsu, R., Hayashi, Y., Yoshida, T., Sasaki, N., Takamaru, Y., Yamaguchi, H., Tateno, M., Fujii, N. and Takahata, N. (1997) Amyloid β protein and transthyretin, sequestrating protein colocalize in normal human kidney Neurosci. Lett. 222, 163-166
16. Tsuzuki, K., Fukatsu, R., Yamaguchi, H., Tateno, M., Imai, K., Fujii, N. and Yamauchi, T. (2000) Transthyretin binds amyloid β peptides, Aβ1-A42 and Aβ1-A40 to form complex in the autopsied human kidney - possible role of transthyretin for Aβ sequestration. Neurosci. Lett. 281, 171-174
17. Higham, C. E., Jaikaran, E. T. A. S., Fraser, P. E., Gross, M. and Clark, A. (2000) Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils. FEBS Lett. 470, 55-60
18. van der Merwe, P. A. (2000) Surface plasmon resonance in protein-ligand interactions: a practical approach (Harding, S. and Chowdhry, P. Z., eds.), Oxford University Press, Oxford
19. LeVine, H. (1999) Quantification of β-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309, 274-284
20. Janciauskiene, S., Eriksson, S., Carlemalm, E. and Ahrén, B. (1997) β-Cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro. Biochem. Biophys. Res. Commun. 236, 580-585
21. Wang, Z. L., Bennet, W. M., Ghatei, M. A., Byfield, P. G., Smith, D. M. and Bloom, S. R. (1993) Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes 42, 330-335
22. Jaikaran, E. T. A. S., Robinson, C. V., Fraser, P. E. and Clark, A. (1998) Insulin and islet amyloid polypeptide 'amylin' form stable molecular complexes. Diabetic Med. 15 (Suppl. 2), S6
23. Dodson, E. J., Dodson, G. G., Hubbard, R. E., Moody, P. C. E., Turkenburg, J., Whittingham, J., Xizo, B., Brange, J., Kaarsholm, N. and Thogersen, H. (1993) Insulin assembly: its modification by protein engineering and ligand binding. Philos. Trans. R. Soc. London Ser. A. 345 153-164
24. Lukinius, A., Wilander, E., Westermark, G. T., Engström, U. and Westermark, P. (1989) Co-localization of islet amyloid polypeptide and insulin in the β-cell secretory granules of the human pancreatic islets. Diabetologia 32, 240-244
25. Jaikaran, E. T. A. S., Higham, C. E., Serpell, L. C., Zurdo, J., Gross, M., Clark, A. and Fraser, P. E. (2001) Identification of a novel human islet amyloid polypeptide β-sheet domain and factors influencing fibrillogenesis. J. Mol. Biol. 308, 515-525
26. Kautzky-Willer, A., Thomaseth, K., Pacini, G., Clodi, M., Ludvik, B., Streli, C., Waldhausl, W. and Prager, R. (1994) Role of islet amyloid polypeptide secretion in insulin-resistant humans. Diabetologia 37, 188-194
27. Kahn, S. E., Verchere, C. B., Andrikopoulos, S., Asberry, P. J., Leonetti, D. L., Wahl, P. W., Boyko, E. J., Schwartz, R. S., Newell-Morris, L. and Fujimoto, W. Y. (1998) Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans, Diabetes. 47, 640-545
28. Clark, A., Holman, R., Matthews, D., Hockaday, T. and Turner, R. (1984) Non-uniform distribution of islet amyloid in the pancreas of 'maturity-onset' diabetic patients. Diabetologia 27, 527-528
29. Westermark, P. and Wilander, E. (1983) Islet amyloid in Type 2 (non-insulin-dependent) diabetes is related to insulin. Diabetologia 24, 342-346
30. Thompson, R. G., Gottlieb, A., Organ, K., Koda, J., Kisicki, J. and Kolterman, O. G. (1997) Pramlintide: a human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes. Diabetic Med. 14, 547-555
31. Hekman, C. M., DeMond, W. S., Kelley, P. J., Mauch, S. F. and Williams, J. D. (1999) Isolation and identification of cyclic imide and deamidation products in heat stressed pramlintide injection drug product. J, Pharm. Biomed. Anal. 20, 763-772
32. Westermark, G. T., Gebre-Medhin, S., Steiner, D. F. and Westermark, P. (2000) Islet amyloid development in a mouse strain lacking endogenous islet amyloid polypeptide (IAPP) but expressing human IAPP. Mol. Med. 6, 998-1007
33. Jaikaran, E. T. A. S. and Clark, A. (2001) Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim. Biophys. Acta 1537, 179-203
34. Halban, P. A. and Kahn, S. E. (1997) Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinaemia of NIDDM. Diabetes 46, 1725-1732